SC-19220

• CAT Number: I009366
• CAS Number: 19395-87-0
• Molecular Formula: C16H14ClN3O3
• Molecular Weight: 331.75
• Purity: ≥95%
• Synonyms: N’-acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide
• IUPAC Name: N'-acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide
• InChI: InChI=1S/C16H14ClN3O3/c1-10(21)18-19-16(22)20-9-11-4-2-3-5-14(11)23-15-7-6-12(17)8-13(15)20/h2-8H,9H2,1H3,(H,18,21)(H,19,22)
• InChIKey: KNURFLJTOUGOOQ-UHFFFAOYSA-N
• SMILES: CC(=O)NNC(=O)N1CC2=CC=CC=C2OC3=C1C=C(C=C3)Cl

SC-19220（Cat No.:I009366）is a selective small molecule inhibitor targeting the p38 mitogen-activated protein kinase (MAPK) pathway, which plays a crucial role in cellular responses to stress, inflammation, and immune signaling. p38 MAPK is implicated in various diseases, including cancer, autoimmune disorders, and chronic inflammation. By inhibiting p38 MAPK, SC-19220 aims to reduce inflammatory responses and modulate immune activity, making it a potential therapeutic candidate for conditions like rheumatoid arthritis, cardiovascular diseases, and certain cancers. SC-19220’s targeted inhibition of p38 MAPK offers a promising approach to treating inflammation-driven diseases.